108 BioCapital today announced that it is leading a financing round in SedMed, Inc. with a $4 million investment. The financing will support SedMed’s next phase of commercial growth and expand access to its non-electric toilet lift, which is designed to help older adults and individuals with mobility limitations sit and stand more safely and independently while reducing strain on caregivers.
How 108 BioCapital is Transforming Mobility Solutions
SedMed is a medical device company developing non-electric mobility solutions that help older adults and individuals with limited mobility sit and stand more safely and independently while reducing physical strain on caregivers. Its flagship product, the SedMed Toilet Lift, attaches to most standard toilets and provides adjustable sit-to-stand assistance without electricity, batteries or bathroom remodeling.
“SedMed is addressing an important and often overlooked challenge for older adults, individuals with limited mobility and their caregivers,” said Sasha Bakhru, Managing Partner of 108 BioCapital. “The company has developed an intuitive, non-electric solution with the potential to improve safety, preserve independence and reduce caregiver burden across home and healthcare settings. We have been impressed by Jeremy and the SedMed team’s thoughtful approach to product development and commercialization, and we are pleased to lead this investment and support the company’s next phase of growth.”
SedMed will use the investment to accelerate commercial expansion, grow its distribution and channel partnerships, advance its intellectual property portfolio and conduct additional hospital-based studies.
“SedMed’s adoption across more than 40 hospital systems demonstrates strong demand for its solution and validates the important role it can play in addressing a significant challenge for healthcare providers,” said Shahryar Oveissi, General Partner of 108 BioCapital. “That momentum also sets the stage for SedMed to become a trusted solution for older adults living at home, where physical limitations, cognitive decline and environmental barriers can increase the risk of accidents and place added strain on caregivers.”
“SedMed’s practical, non-electric design gives the product meaningful potential beyond the United States,” said Shom Jagtiani, General Partner of 108 BioCapital. “We see particular opportunity in India and other international markets, where an easy-to-deploy solution could help improve bathroom safety and independence for older adults across home and healthcare settings.”
“This investment represents an important milestone for SedMed as we work to make safer bathroom mobility accessible to more people,” said Jeremy Bronen, CEO of SedMed. “108 BioCapital brings healthcare expertise and a shared commitment to supporting technologies that can meaningfully improve the lives of patients and caregivers. This funding will allow us to expand our commercial reach, strengthen our distribution network and build additional evidence demonstrating the value SedMed can provide to healthcare organizations.”